Apellis Pharmaceuticals, Inc.
SEC CIK 1492422 · APLS · last insider filing 2026-05-14
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Wheeler Craig A | Director | filed 2025 - 2026 |
| Dolsten Mikael | Director | filed 2026 - 2026 |
| Machiels Alec | Director | filed 2017 - 2026 |
| Chan Gerald | Director | filed 2017 - 2026 |
| Francois Cedric | Director · Chief Executive Officer | filed 2017 - 2026 |
| O'Brien Stephanie Monaghan | Director | filed 2017 - 2026 |
| Dunlop A. Sinclair | Director | filed 2017 - 2026 |
| Fonteyne Paul R. | Director | filed 2020 - 2026 |
| Walbert Keli | Director | filed 2025 - 2026 |
| Chen Bihua | Director | filed 2017 - 2017 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Watson David O. | General Counsel | filed 2017 - 2026 |
| Deschatelets Pascal | Chief Scientific Officer | filed 2017 - 2026 |
| Sullivan Timothy Eugene | Chief Financial Officer | filed 2017 - 2026 |
| Nicholson Nur | Chief Technical Officer | filed 2020 - 2026 |
| Chopas James George | VP/Chief Accounting Officer | filed 2021 - 2026 |
| Delong Mark Jeffrey | Senior Vice President | filed 2021 - 2026 |
| Baumal Caroline | Chief Medical Officer | filed 2023 - 2026 |
| Boucher Kelley | Chief People Officer | filed 2025 - 2026 |
| Meltzer Leslie | Chief Research and Development | filed 2025 - 2026 |
| Townsend Adam J. | See Remarks | filed 2019 - 2025 |
| Lewis Karen | Chief People Officer | filed 2020 - 2025 |
| Eisele Jeffrey | See Remarks | filed 2020 - 2025 |
| Scheibler Lukas | See Remarks | filed 2018 - 2023 |
| Brown Victoria L. | Program Team Lead | filed 2020 - 2023 |
| Grossi Federico | See Remarks | filed 2017 - 2023 |
| Perry Nicole D | Vice President - Finance | filed 2017 - 2021 |
| Celona Lucia | See Remarks | filed 2019 - 2020 |
| Lackner Thomas A. | See Remarks | filed 2019 - 2020 |
| Sadr Ahmad | See Remarks | filed 2019 - 2020 |
| Axon Steven | Chief Business Officer | filed 2017 - 2018 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.